Show simple item record

dc.contributor.authorCastillo Barnes, Diego
dc.contributor.authorRamírez Pérez De Inestrosa, Javier
dc.contributor.authorSegovia Román, Fermín
dc.contributor.authorMartínez Murcia, Francisco J.
dc.contributor.authorGorriz Sáez, Juan Manuel
dc.date.accessioned2019-11-18T12:19:17Z
dc.date.available2019-11-18T12:19:17Z
dc.date.issued2018-08-14
dc.identifier.citationCastillo-Barnes D, Ramírez J, Segovia F, Martínez-Murcia FJ, Salas-Gonzalez D and Górriz JM (2018) Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson’s Disease. Front. Neuroinform. 12:53.es_ES
dc.identifier.urihttp://hdl.handle.net/10481/57957
dc.description.abstractIn last years, several approaches to develop an effective Computer-Aided-Diagnosis (CAD) system for Parkinson’s Disease (PD) have been proposed. Most of these methods have focused almost exclusively on brain images through the use of Machine-Learning algorithms suitable to characterize structural or functional patterns. Those patterns provide enough information about the status and/or the progression at intermediate and advanced stages of Parkinson’s Disease. Nevertheless this information could be insufficient at early stages of the pathology. The Parkinson’s ProgressionMarkers Initiative (PPMI) database includes neurological images along with multiple biomedical tests. This information opens up the possibility of comparing different biomarker classification results. As data come from heterogeneous sources, it is expected that we could include some of these biomarkers in order to obtain new information about the pathology. Based on that idea, this work presents an Ensemble Classification model with Performance Weighting. This proposal has been tested comparing Healthy Control subjects (HC) vs. patients with PD (considering both PD and SWEDD labeled subjects as the same class). This model combines several Support-Vector-Machine (SVM) with linear kernel classifiers for different biomedical group of tests—including CerebroSpinal Fluid (CSF), RNA, and Serum tests—and pre-processed neuroimages features (Voxels-As-Features and a list of definedMorphological Features) fromPPMI database subjects. The proposed methodology makes use of all data sources and selects the most discriminant features (mainly from neuroimages). Using this performance-weighted ensemble classification model, classification results up to 96% were obtained.es_ES
dc.description.sponsorshipThis work was supported by the MINECO/FEDER under the TEC2015-64718-R project and the Ministry of Economy, Innovation, Science and Employment of the Junta de Andalucía under the Excellence Project P11-TIC-7103.es_ES
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectMachine learninges_ES
dc.subjectParkinson´s diseasees_ES
dc.subjectBiomarkerses_ES
dc.titleRobust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson’s Diseasees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3389/fninf.2018.00053


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España